% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Tessonnier:212415,
author = {T. Tessonnier and S. Ecker and J. Besuglow$^*$ and J.
Naumann and S. Mein$^*$ and F. K. Longarino$^*$ and M.
Ellerbrock and B. Ackermann and M. Winter and S. Brons and
A. Qubala and T. Haberer and J. Debus$^*$ and O. Jäkel$^*$
and A. Mairani$^*$},
title = {{C}ommissioning of helium ion therapy and the first patient
treatment with active beam delivery.},
journal = {International journal of radiation oncology, biology,
physics},
volume = {116},
number = {4},
issn = {0360-3016},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DKFZ-2023-00134},
pages = {935-948},
year = {2023},
note = {#EA:E050#LA:E050#LA:E040# / 2023 Jul 15;116(4):935-948},
abstract = {Helium ions offer intermediate physical and biological
properties to the clinically used protons and carbon ions.
This work presents the commissioning of the first clinical
treatment planning system (TPS) for helium ion therapy with
active beam delivery to prepare the first patients'
treatment at the INSTITUTION-XXX METHODS: : Through
collaboration between RaySearch Laboratories and
INSTITUTION-XXX, absorbed and relative biological
effectiveness (RBE)-weighted calculation methods were
integrated for helium ion beam therapy with raster-scanned
delivery in the TPS RayStation. At INSTITUTION-XXX, a
modified Microdosimetric Kinetic biological Model was chosen
as reference biological model. TPS absorbed dose predictions
were compared against measurements with several devices,
using phantoms of different complexities, from homogeneous
to heterogeneous anthropomorphic phantoms. RBE and
RBE-weighted dose predictions of the TPS were verified
against calculations with an independent RBE-weighted dose
engine. The patient specific quality-assurance of the first
treatment at INSTITUTION-XXX using helium ion beam with
raster-scanned delivery is presented considering standard
patient-specific measurements in a water phantom and two
independent dose calculations with a Monte-Carlo or an
analytical-based engine.TPS predictions were consistent with
dosimetric measurements and independent dose engines
computations for absorbed and RBE-weighted doses. The mean
difference between dose measurements to the TPS calculation
was $0.2\%$ for spread-out Bragg peaks in water.
Verification of the first patient treatment TPS predictions
against independent engines for both absorbed and
RBE-weighted doses presents differences within $2\%$ in the
target and with a maximum deviation of $3.5\%$ in the
investigated critical regions of interest.Helium ion beam
therapy has been successfully commissioned and introduced
into clinical use. Through comprehensive validation of the
absorbed and RBE-weighted dose predictions of the RayStation
TPS, the first clinical TPS for helium ion therapy using
raster-scanned delivery was employed to plan the first
helium patient treatment at INSTITUTION-XXX.},
keywords = {Helium ions (Other) / Treatment planning system (Other) /
commissioning (Other) / particle therapy (Other)},
cin = {E050 / E040 / HD01},
ddc = {610},
cid = {I:(DE-He78)E050-20160331 / I:(DE-He78)E040-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36681200},
doi = {10.1016/j.ijrobp.2023.01.015},
url = {https://inrepo02.dkfz.de/record/212415},
}